Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
Positivities ofcombined tumour marker tests in patients with diseases... | Download Table
Antygen CA-19-9 badanie | Marker nowotworowy układu pokarmowego
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA-19-9 - Diagnostic Kit
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Tumor markeri - Poliklinika Irac
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
Comparison of the performance of total CA 19-9 and the marker panel in... | Download Table
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review - M J Duffy, 1998
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar